Chinese General Practice ›› 2025, Vol. 28 ›› Issue (05): 587-593.DOI: 10.12114/j.issn.1007-9572.2023.0924
Special Issue: 衰弱最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2024-04-10
Revised:
2024-07-09
Published:
2025-02-15
Online:
2024-11-25
Contact:
MA Qing
通讯作者:
马清
作者简介:
作者贡献:
石小天提出主要研究目标,负责研究的构思与设计,研究的实施,撰写论文;石小天、杨一帆、李旭、窦国泽进行数据的收集与整理,统计学处理,图、表的绘制与展示;王珊、杨华昱进行论文的修订;马清负责文章的质量控制与审查,对文章整体负责,监督管理。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0924
组别 | 例数 | 性别[例(%)] | 年龄[M(P25,P75),岁] | BMI [M(P25,P75),kg/m2] | 文化程度[例(%)] | 多重用药[例(%)] | ||||
---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 高中以下 | 高中 | 大学及以上 | 是 | 否 | ||||
无衰弱组 | 341 | 259(75.95) | 82(24.05) | 71.0(65.0,80.0) | 24.37(22.42,26.21) | 7(2.05) | 23(6.74) | 311(91.20) | 85(24.93) | 256(75.07) |
衰弱/衰弱前期组 | 213 | 154(72.30) | 59(25.70) | 79.0(68.0,86.0) | 23.91(21.92,26.10) | 12(5.63) | 14(6.57) | 187(87.79) | 103(48.36) | 110(51.64) |
检验统计量值 | 0.920a | -6.166 | -1.398 | 5.078a | 32.104a | |||||
P值 | 0.337 | <0.001 | 0.162 | 0.079 | <0.001 | |||||
组别 | 独居[例(%)] | 吸烟[例(%)] | 饮酒[例(%)] | MNA-SF评分[M(P25,P75),分] | ACCI [M(P25,P75),分] | 糖化血红蛋白[M(P25,P75),%] | ||||
是 | 否 | 是 | 否 | 是 | 否 | |||||
无衰弱组 | 28(8.21) | 313(91.79) | 46(13.49) | 295(86.51) | 109(31.96) | 232(68.04) | 14.00(13.00,14.00) | 3.00(2.00,4.00) | 5.97(5.67,6.42) | |
衰弱/衰弱前期组 | 19(8.92) | 194(91.08) | 28(13.15) | 185(86.85) | 54(25.35) | 159(74.65) | 13.00(12.00,14.00) | 4.00(3.00,5.00) | 5.89(5.60,6.24) | |
检验统计量值 | 0.085a | 0.013a | 2.761a | -4.920 | -6.569 | -1.768 | ||||
P值 | 0.771 | 0.908 | 0.097 | <0.001 | <.001 | 0.077 | ||||
组别 | 白蛋白(g/L) | 白细胞计数[M(P25,P75),×109/L] | 中性粒细胞绝对值[M(P25,P75),×109/L] | 淋巴细胞绝对值[M(P25,P75),×109/L] | 单核细胞绝对值[M(P25,P75),×109/L] | 红细胞[M(P25,P75),×1012/L] | 血红蛋白[M(P25,P75),g/L] | |||
无衰弱组 | 44.07±2.57 | 6.14(5.28,7.25) | 3.47(2.81,4.30) | 2.21(1.71,2.65) | 0.29(0.23,0.38) | 4.73(4.46,4.96) | 148.00(140.00,155.00) | |||
衰弱/衰弱前期组 | 42.96±2.91 | 6.21(5.23,7.38) | 3.52(2.87,4.39) | 2.10(1.62,2.51) | 0.29(0.23,0.35) | 4.61(4.22,4.83) | 142.00(132.00,151.00) | |||
检验统计量值 | 4.169b | -0.115 | -0.817 | -2.497 | -0.732 | -3.786 | -4.856 | |||
P值 | <0.001 | 0.909 | 0.414 | 0.013 | 0.464 | <0.001 | <0.001 | |||
组别 | 红细胞体积分布宽度[M(P25,P75),fL] | 血小板计数[M(P25,P75),×109/L] | 血小板体积分布宽度[M(P25,P75),%] | 总胆固醇[M(P25,P75),μmol/L] | 三酰甘油[M(P25,P75),μmol/L] | 高密度脂蛋白[M(P25,P75),μmol/L] | ||||
无衰弱组 | 43.60(41.70,45.20) | 211.00(183.00,244.00) | 11.50(10.70,12.50) | 4.80(4.20,5.57) | 1.26(0.98,1.71) | 1.19(1.03,1.37) | ||||
衰弱/衰弱前期组 | 44.30(42.60,45.90) | 206.00(172.00,244.00) | 11.50(10.40,12.50) | 4.65(3.85,5.45) | 1.14(0.85,1.68) | 1.23(1.02,1.48) | ||||
检验统计量值 | -2.702 | -1.541 | -0.868 | -2.560 | -2.896 | -1.030 | ||||
P值 | 0.007 | 0.123 | 0.386 | 0.010 | 0.004 | 0.303 | ||||
组别 | 低密度脂蛋白[M(P25,P75),μmol/L] | NLR [M(P25,P75)] | dNLR [M(P25,P75)] | HRR [M(P25,P75)] | MLR [M(P25,P75)] | PLR [M(P25,P75)] | PRP [M(P25,P75)] | |||
无衰弱组 | 2.93(2.51,3.47) | 1.54(1.19,2.06) | 1.74(1.39,2.35) | 3.41(3.16,3.61) | 0.14(0.10,0.18) | 96.70(77.25,118.22) | 0.21(0.18,0.24) | |||
衰弱/衰弱前期组 | 2.67(2.19,3.26) | 1.73(1.30,2.31) | 2.00(1.53,2.63) | 3.23(2.97,3.48) | 0.14(0.11,0.19) | 96.40(79.61,124.30) | 0.21(0.18,0.27) | |||
检验统计量值 | -4.220 | -2.681 | -2.955 | -4.942 | -1.340 | -0.905 | -2.037 | |||
P值 | <0.001 | 0.007 | 0.003 | <0.001 | 0.180 | 0.365 | 0.042 |
Table 1 Clinical features in the elderly of non-frail group versus frail/pre-frail group
组别 | 例数 | 性别[例(%)] | 年龄[M(P25,P75),岁] | BMI [M(P25,P75),kg/m2] | 文化程度[例(%)] | 多重用药[例(%)] | ||||
---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 高中以下 | 高中 | 大学及以上 | 是 | 否 | ||||
无衰弱组 | 341 | 259(75.95) | 82(24.05) | 71.0(65.0,80.0) | 24.37(22.42,26.21) | 7(2.05) | 23(6.74) | 311(91.20) | 85(24.93) | 256(75.07) |
衰弱/衰弱前期组 | 213 | 154(72.30) | 59(25.70) | 79.0(68.0,86.0) | 23.91(21.92,26.10) | 12(5.63) | 14(6.57) | 187(87.79) | 103(48.36) | 110(51.64) |
检验统计量值 | 0.920a | -6.166 | -1.398 | 5.078a | 32.104a | |||||
P值 | 0.337 | <0.001 | 0.162 | 0.079 | <0.001 | |||||
组别 | 独居[例(%)] | 吸烟[例(%)] | 饮酒[例(%)] | MNA-SF评分[M(P25,P75),分] | ACCI [M(P25,P75),分] | 糖化血红蛋白[M(P25,P75),%] | ||||
是 | 否 | 是 | 否 | 是 | 否 | |||||
无衰弱组 | 28(8.21) | 313(91.79) | 46(13.49) | 295(86.51) | 109(31.96) | 232(68.04) | 14.00(13.00,14.00) | 3.00(2.00,4.00) | 5.97(5.67,6.42) | |
衰弱/衰弱前期组 | 19(8.92) | 194(91.08) | 28(13.15) | 185(86.85) | 54(25.35) | 159(74.65) | 13.00(12.00,14.00) | 4.00(3.00,5.00) | 5.89(5.60,6.24) | |
检验统计量值 | 0.085a | 0.013a | 2.761a | -4.920 | -6.569 | -1.768 | ||||
P值 | 0.771 | 0.908 | 0.097 | <0.001 | <.001 | 0.077 | ||||
组别 | 白蛋白(g/L) | 白细胞计数[M(P25,P75),×109/L] | 中性粒细胞绝对值[M(P25,P75),×109/L] | 淋巴细胞绝对值[M(P25,P75),×109/L] | 单核细胞绝对值[M(P25,P75),×109/L] | 红细胞[M(P25,P75),×1012/L] | 血红蛋白[M(P25,P75),g/L] | |||
无衰弱组 | 44.07±2.57 | 6.14(5.28,7.25) | 3.47(2.81,4.30) | 2.21(1.71,2.65) | 0.29(0.23,0.38) | 4.73(4.46,4.96) | 148.00(140.00,155.00) | |||
衰弱/衰弱前期组 | 42.96±2.91 | 6.21(5.23,7.38) | 3.52(2.87,4.39) | 2.10(1.62,2.51) | 0.29(0.23,0.35) | 4.61(4.22,4.83) | 142.00(132.00,151.00) | |||
检验统计量值 | 4.169b | -0.115 | -0.817 | -2.497 | -0.732 | -3.786 | -4.856 | |||
P值 | <0.001 | 0.909 | 0.414 | 0.013 | 0.464 | <0.001 | <0.001 | |||
组别 | 红细胞体积分布宽度[M(P25,P75),fL] | 血小板计数[M(P25,P75),×109/L] | 血小板体积分布宽度[M(P25,P75),%] | 总胆固醇[M(P25,P75),μmol/L] | 三酰甘油[M(P25,P75),μmol/L] | 高密度脂蛋白[M(P25,P75),μmol/L] | ||||
无衰弱组 | 43.60(41.70,45.20) | 211.00(183.00,244.00) | 11.50(10.70,12.50) | 4.80(4.20,5.57) | 1.26(0.98,1.71) | 1.19(1.03,1.37) | ||||
衰弱/衰弱前期组 | 44.30(42.60,45.90) | 206.00(172.00,244.00) | 11.50(10.40,12.50) | 4.65(3.85,5.45) | 1.14(0.85,1.68) | 1.23(1.02,1.48) | ||||
检验统计量值 | -2.702 | -1.541 | -0.868 | -2.560 | -2.896 | -1.030 | ||||
P值 | 0.007 | 0.123 | 0.386 | 0.010 | 0.004 | 0.303 | ||||
组别 | 低密度脂蛋白[M(P25,P75),μmol/L] | NLR [M(P25,P75)] | dNLR [M(P25,P75)] | HRR [M(P25,P75)] | MLR [M(P25,P75)] | PLR [M(P25,P75)] | PRP [M(P25,P75)] | |||
无衰弱组 | 2.93(2.51,3.47) | 1.54(1.19,2.06) | 1.74(1.39,2.35) | 3.41(3.16,3.61) | 0.14(0.10,0.18) | 96.70(77.25,118.22) | 0.21(0.18,0.24) | |||
衰弱/衰弱前期组 | 2.67(2.19,3.26) | 1.73(1.30,2.31) | 2.00(1.53,2.63) | 3.23(2.97,3.48) | 0.14(0.11,0.19) | 96.40(79.61,124.30) | 0.21(0.18,0.27) | |||
检验统计量值 | -4.220 | -2.681 | -2.955 | -4.942 | -1.340 | -0.905 | -2.037 | |||
P值 | <0.001 | 0.007 | 0.003 | <0.001 | 0.180 | 0.365 | 0.042 |
因素 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
MNA-SF评分 | -0.34 | 0.08 | -4.36 | <0.001 | 0.71(0.61~0.83) |
ACCI | 0.35 | 0.08 | 4.33 | <0.001 | 1.42(1.21~1.66) |
HRR | -0.81 | 0.34 | -2.40 | 0.016 | 0.44(0.23~0.86) |
多重用药(以是为参考) | |||||
否 | -0.62 | 0.21 | -2.93 | 0.003 | 0.54(0.36~0.81) |
Table 2 Multivariate Logistic regression analysis on influencing factors of frailty/pre-frailty in the elderly
因素 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
MNA-SF评分 | -0.34 | 0.08 | -4.36 | <0.001 | 0.71(0.61~0.83) |
ACCI | 0.35 | 0.08 | 4.33 | <0.001 | 1.42(1.21~1.66) |
HRR | -0.81 | 0.34 | -2.40 | 0.016 | 0.44(0.23~0.86) |
多重用药(以是为参考) | |||||
否 | -0.62 | 0.21 | -2.93 | 0.003 | 0.54(0.36~0.81) |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
中华医学会老年医学分会,《中华老年医学杂志》编辑委员会. 老年人衰弱预防中国专家共识(2022)[J]. 中华老年医学杂志,2022,41(5):503-511. DOI:10.3760/cma.j.issn.0254-9026.2022.05.001.
|
[13] |
中国老年医学学会营养与食品安全分会,中国循证医学中心,《中国循证医学杂志》编辑委员会,等. 老年患者家庭营养管理中国专家共识(2017版)[J]. 中国循证医学杂志,2017,17(11):1251-1259. DOI:10.7507/1672-2531.201707095.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[1] | JIA Gaopeng, CHEN Qiuyu. Construction and Validation of a Risk Prediction Model for Recurrent Angina after Percutaneous Coronary Intervention in Elderly Patients with Acute ST-segment Elevation Myocardial Infarction: Based on CYP2C19-related Genetic Testing [J]. Chinese General Practice, 2025, 28(30): 3779-3786. |
[2] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[3] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[4] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[5] | ZHU Chen, YU Jiawen, JIANG Hao, GAN Panpan, XIA Tian, XU Haitao, DU Yingying. Research on the Predictive Value of Lipid Characteristics about Digestive System Tumors for Normal Phase Angles [J]. Chinese General Practice, 2025, 28(27): 3385-3390. |
[6] | CHENG Yuxin, FANG Jiamin, LIANG Hao, WANG Zhiling, WEI Li, LIAO Huilian, XU Mingming, CHEN Yumei, LI Yanfen, DONG Lijuan, GUO Yingui. Preoperative Platelet-to-albumin Ratio in Elective Geriatric Surgery Patients and Its Correlation with Postoperative Incidental Frailty: a Multicenter Study [J]. Chinese General Practice, 2025, 28(27): 3359-3367. |
[7] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[8] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[9] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[10] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[11] | ZHAO Xiaoqing, GUO Tongtong, ZHANG Xinyi, LI Linhong, ZHANG Ya, JI Lihong, DONG Zhiwei, GAO Qianqian, CAI Weiqing, ZHENG Wengui, JING Qi. Construction and Validation of a Risk Prediction Model for Cognitive Impairment in Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(22): 2776-2783. |
[12] | GUO Shengteng, ZHANG Fenfen, WAN Di, YU Dongmei, WANG Qinghua. Risk Factors for Severe Acute Pancreatitis Complicated with Acute Lung Injury: a Meta-analysis [J]. Chinese General Practice, 2025, 28(20): 2546-2554. |
[13] | ZHANG Bingqing, WANG Zhongkai, WU Changyong, SUN Huang, LI Ruijie, LIU Wenjie, LUO Yihua, ZHENG Lihui, PENG Yunzhu. Changes and Trend Prediction in the Global Burden of Congenital Heart Defects, 1990-2021 [J]. Chinese General Practice, 2025, 28(18): 2253-2261. |
[14] | JIANG Xiaoman, XU Xinyi, DING Lingyu, GUO Yinning, MIAO Xueyi, CHEN Li, XU Qin. Clinical Characteristics and Correlation between Preoperative Frailty and Metabolic Syndrome among Older Patients with Gastric Cancer [J]. Chinese General Practice, 2025, 28(17): 2134-2141. |
[15] | ZHOU Yunzhe, MIAO Junxiang, WEI Jiehua, CHEN Lizhang, WANG Tingting. Study on the Association between Polymorphisms and Interaction of CCND1 and CCNE1 Genes with Preeclampsia [J]. Chinese General Practice, 2025, 28(17): 2142-2148. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||